Academic rejects ‘fuzzy math’ claim in spat over curcumin bioavailability

By Elaine Watson

- Last updated on GMT

Related tags: Alzheimer's disease

Turmeric contains curcumin, a powerful anti-inflammatory agent
Turmeric contains curcumin, a powerful anti-inflammatory agent
The authors of a recent study into curcumin bioavailability have rejected claims by a cancer researcher that “fuzzy math” led them to overestimate the absorption of the anti-inflammatory agent curcumin from some supplement formulations.

Giovanni Appendino is professor of organic chemistry at the University of Eastern Piedmont, scientific advisor at natural ingredients supplier Indena, and co-author of the Cuomo et al study ​on curcumin just published in the Journal of Natural Products​.

He was speaking to NutraIngredients-USA.com after curcumin supplier EuroPharma issued a press release ​containing comments from Dr Ajay Goel, director of epigenetics and cancer prevention at the Gastrointestinal Research Center at Baylor University Medical Center in Dallas, challenging the study's figures.

In the release, Goel, who sits on EuroPharma’s scientific advisory board, said he had analyzed BCM-95 (a curcumin extract from EuroPharma), plain curcumin, and the Meriva curcumin phytosome used in the Cuomo study, and said the claimed increases in absorption in the study did not take into account the fact that less than a fifth of the phytosome was curcumin.

“The consequence of this mad race to discover the best curcumin preparation available in the marketplace has led to misleading marketing claims comparing curcumin absorption to turmeric in some instances, and fuzzy math and statistics in interpreting studies on curcumin with special absorption systems.”

He added: “The two most important measures that support scientific logic remain. What levels of full-spectrum of curcuminoids can be detected in the blood? And how long do the curcuminoids remain in the blood stream within the therapeutic range?”

Appendino: Our math is correct

However, Appendino said: “We do not boast anything. We claim that curcuminoids are better absorbed from this​ [Meriva] formulation (by 29-fold) compared with unformulated curcumin. The fact that Meriva is only 20 percent curcumin is clearly stated​.

“On a weight basis, the improved absorption of curcuminoids from Meriva is six-fold, but, if you want to make a fair comparison with other products, you should also include in the comparison all the other formulation ingredients included in the formulation of the other products, like cellulose (also enclosed in the weight calculation of Meriva) or any other formulation adjuvants."

Bioavailability and curcumin

Meanwhile, EuroPharma ​chief of scientific affairs and education Cheryl Myers insisted that BCM-95 remained the most bioavailable product on the market.

She added: “If you emulsify curcumin withphosphatidylcholine​ [from soy lecithin] you have a phytosomewith one part curcumin, two parts lecithin and two parts cellulose, so you get less than 100 mg of actual curcumin in a 500 mg supplement.

“In comparing phytosome blood level results to those of BCM-95 curcumin, our product increased serum levels over twice as much as their curcumin phytosome on an equal weight basis.

“Professor Appendino notes that on an equal weight basis (500 mg curcumin phytosome compared to 500 mg plain curcumin), that is only about a six-fold increase in absorption. Therefore, his 29-fold statistic is not comparing equal amounts of product.To make a 29-fold claim, the authors compared 500 mg curcumin phytosome to only 100 mg plain curcumin and computed the results in that manner."

BCM-95 was produced by a patented process that produced a product with up to 10 times the bioavailability of plain curcumin, she claimed. “We micronize curcumin powder and then blend it with essential oils from turmeric. In each 500 mg of BCM-95 curcumin, there is more than 450 mg full-spectrum curcuminoids.”

Curcumin was poorly absorbed in the human body, she added.“Turmeric only has a tiny percentage of curcumin, which is very poorly absorbed, so you’d have to eat bucket loads of some of the products currently on the market to get any benefit​.”

The science behind curcumin

BCM-95 was recently chosen by leading Alzheimer’s researcher Professor Ralph Martins ​for a new study exploring its ability to arrest the progression of dementia in Alzheimer’s patients at Edith Cowan University in Perth, added Myers.

Animal studies suggested curcumin could help reverse the build up of neural (beta amyloid) plaque implicated in Alzheimer's, she added. But more human intervention studies were needed. Professor Martin’s study was looking specifically at cognitive function and behavior, which would take the research onto a new level, she said.

Related news

Show more

Related products

show more

Welcome to Blue California Specialty Ingredients

Welcome to Blue California Specialty Ingredients

Blue California | 11-Oct-2021 | Product Presentation

At Blue California, our mission is to produce innovative and sustainable, custom ingredient solutions that are not just unique, they are also inspirational...

Whole-Body Solutions, Backed by Science

Whole-Body Solutions, Backed by Science

Kemin Human Nutrition and Health | 14-Sep-2021 | Technical / White Paper

Kemin Human Nutrition and Health develops products and services with its mission top of mind: healthy people, planet, and business. We strive to sustainably...

Vitamin K2 Amplifies Vitamin D3’s Impact

Vitamin K2 Amplifies Vitamin D3’s Impact

NattoPharma – Gnosis by Lesaffre | 06-Sep-2021 | Data Sheet

Few vitamins work better together than Vitamins K2 and D3. Both fat-soluble vitamins play a central role in how the body utilizes calcium, synergistically...

Absocurcumin® - A Botanic Joint Health Ingredient

Absocurcumin® - A Botanic Joint Health Ingredient

BOTANIC HEALTHCARE (NZ) LTD | 02-Sep-2021 | Clinical Study

ABSOCURCUMIN® is a clinically proven standardized phytochemical composition derived from Turmeric, Curcuma longa. In a controlled study of 30 adults aged...

Related suppliers

2 comments

Progress

Posted by David Boothman,

This is all very encouraging. A few years ago turmeric was dismissed by most scientists ase witchcraft from a backward culture because it could not be patented and so would interfere wt the real reason for health a and drug research, to secure research money or to make money from patentable drug sales. Now we have different science groups arguing over who has the right approach. Has the cartel finally been breached?

Report abuse

Curcumin turmeric questions

Posted by Bill Sardi,

While the amount of curcumin in turmeric is very small, even small amouts are biologically significant, though fermented polyphenols, such as found in wine, increase the amount of polyphenol concentration and make them more effective. There is confusion over absorption and bioavailability. Absorption is in the gut whereas bioavailability is determined by how much of a molecule is found in the blood circulation after liver detoxification. The liver produces sulfate and glucuronate to intercept and attach to polyphenols like curcumin, temporarily rendering polyphenols non-bioavailable. An unzipping enzyme, glucuronidase, abundant at sites of inflammation, infection and infection, releases unbound polyphenols at the needed site. This is nature's drug deliver system. Glucuronidation and sulfation prolongs the half-life of polyphenols in the blood stream from minutes to hours. Lecithinized polyphenols will absorb a bit better. The comparison between turmeric and curcumin may be a bit flawed, but the idea of creating a phytosome is attractive.

Report abuse

Follow us

Products

View more

Webinars